Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli

20263 citationsJournal Articlegreen Open Access

Authors

Ole De Backer · Justus-Liebig-Universität Gießen

Arif Khokhar · Rigshospitalet

Gintautas Bieliauskas · Rigshospitalet

Azeem Latib · Albert Einstein College of Medicine

Rishi Puri · Cleveland Clinic

Tamaz Shaburishvili · United Heart and Vascular Clinic

Maia Zhividze ·

Abstract

In patients with SAA, the DurAVR THV demonstrated promising clinical and echocardiographic outcomes at 30 days. Longer-term follow-up in larger cohorts is needed to confirm these encouraging early results.

Topics & Keywords

Cardiac Valve Diseases and Treatments Aortic Disease and Treatment Approaches Congenital Heart Disease Studies

Publication Details

Published in: EuroIntervention

Volume 22, Issue 3, pp. e150-e160

DOI: 10.4244/eij-d-25-01106

Field-Weighted Citation Impact: 93.37

Command Palette

Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli

Authors

Abstract

Topics & Keywords

Publication Details